International Continence Society best practice statement for use of sacral neuromodulation
Howard B. Goldman(Cleveland Clinic), Steven Siegel(Comprehensive OBGYN), Jerzy B. Gajewski(Dalhousie University), Emmanuel Chartier‐Kastler(Sorbonne Université), Paul‐Antoine Lehur(Centre Hospitalier Universitaire de Nantes), Klaus E. Matzel(Friedrich-Alexander-Universität Erlangen-Nürnberg), Karen Noblett(University of California, Irvine), Jessica C. Lloyd(Cleveland Clinic), Marcus Carey(Epworth Hospital), Ian M. Paquette(University of Cincinnati), Juan Carlos Castaño Botero(Universidad CES), Magdy Hassouna(Warrington and Halton Teaching Hospitals NHS Foundation Trust), Michael Ehlert(Comprehensive OBGYN), Stefan De Wachter(University of Bern)
Cited by 173
Related Papers
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis
|Critical Care Medicine|1997|863
Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer
|JAMA Oncology|2016|721
The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Treatment of Left-Sided Colonic Diverticulitis
|Diseases of the Colon & Rectum|2020|461
Clinical Practice Guideline for the Management of Anorectal Abscess, Fistula-in-Ano, and Rectovaginal Fistula
|Diseases of the Colon & Rectum|2016|395
The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Colon Cancer
|Diseases of the Colon & Rectum|2021|370